C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map

Anton G Kutikhin1, Arseniy E Yuzhalin

  • 1Department of Epidemiology, Kemerovo State Medical Academy, Kemerovo, Russian Federation.

Insights

Genetic variations in C-type lectin receptors and RIG-I-like receptors may influence cancer risk. Further research is needed to understand the link between these pattern recognition receptor polymorphisms and cancer progression.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • Pattern recognition receptors (PRRs) are crucial for detecting infectious agents, including oncogenic ones, and initiating immune responses.
  • Inherited variations in PRR genes can impact immune function and potentially influence cancer risk and progression.
  • While Toll-like receptors (TLRs) and NOD-like receptors (NLRs) have been studied, C-type lectin receptors (CLRs) and RIG-I-like receptors (RLRs) in relation to cancer remain under-investigated.

Purpose of the Study:

  • To highlight the potential role of genetic polymorphisms in CLRs and RLRs in cancer risk and progression.
  • To address the gap in research concerning CLR and RLR gene variations and their association with oncogenesis.
  • To identify specific single nucleotide polymorphisms (SNPs) within CLR and RLR genes that warrant further investigation in cancer research.

Main Methods:

  • Review of existing literature on PRRs, genetic variations, and cancer.
  • Analysis of the functional consequences of CLR and RLR polymorphisms.
  • Identification of candidate SNPs associated with various cancer types.

Main Results:

  • Evidence suggests that inherited variations in CLRs and RLRs may be associated with increased cancer risk.
  • Functional consequences of certain CLR and RLR polymorphisms can indirectly modulate cancer risk.
  • Specific SNPs (e.g., rs1926736, rs2478577) are proposed as promising targets for oncogenomic studies.

Conclusions:

  • Polymorphisms in CLR and RLR genes may correlate with the risk of developing various cancers, including lung, colorectal, and liver cancer.
  • These genetic variations could influence cancer risk indirectly by affecting the recognition of oncogenic pathogens.
  • Further research into CLR and RLR gene polymorphisms is essential for understanding their role in cancer development and progression.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: